 
    Ibis Capital Partners is an investment banking firm focused on M&A advisory, management consulting.
Ibis Capital Partners is an investment banking firm focused on M&A advisory, management consulting.
| Announced Date | Fund Name | Money Raised | |
|---|---|---|---|
| Apr 3, 2017 | OS Investment | ¥10B | |
| Oct 31, 2016 | Ibis New Growth Fund IV | - | |
| Jun 30, 2014 | Ibis New Growth Fund II | - | |
| May 31, 2013 | Ibis Support Investment Fund | - | |
| May 31, 2013 | Ibis New Growth Investment Fund | - | 
| 
                        Date
                        Company Name
                     | Round | Money Raised | Industry | Lead Investor | 
|---|---|---|---|---|
| 
                      Feb 18, 2020
                      
                            YAMATO | Series Unknown | — | Artificial Intelligence | — | 
| 
                      Feb 18, 2020
                      
                            Yamato Holdings | Post-IPO Equity | — | Delivery Service | Yes | 
| 
                      Nov 18, 2019
                      
                            Standard Capital | Seed | ¥3.28B | Business Intelligence | — | 
| 
                      May 22, 2018
                      
                            A.L.I. Technologies Japan | Series Unknown | ¥88.75M | Aerospace | — | 
| 
                      Nov 28, 2017
                      
                            AI CROSS | Series Unknown | ¥300M | Artificial Intelligence | — | 
Ibis Capital Partners has had 2 exits. Ibis Capital Partners most notable exits include AI CROSS , BrightPath Biotherapeutics
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Oct 8, 2019 | AI CROSS | IPO | Artificial Intelligence | Detail | 
| Oct 22, 2015 | BrightPath Biotherapeutics | IPO | Biotechnology | Detail |